SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

ran

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-ran
Related Entities
RAN
Metadata
sluggenes-ran
entity_typegene
kg_node_idRAN
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (431)
see_also📖Cell-Free DNA Biomarkers in Neurodegeneration80%
see_also📖Exosomal Biomarkers in Neurodegeneration80%
see_also📖Exosomal miR-155 in Neurodegeneration80%
see_also📖IL-6 (Interleukin-6) in Neurodegeneration80%
see_also📖Liquid Biopsy in Neurodegeneration80%
see_also📖Metabolomic Biomarkers in Neurodegeneration80%
see_also📖Neuroimaging Biomarkers for Neurodegeneration80%
see_also📖Synaptic Biomarkers in Neurodegeneration80%
see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and80%
see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl80%
see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 80%
see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)80%
see_also📖China Neurodegeneration Epidemiology80%
see_also📖DALY Methodology — Neurodegeneration80%
see_also📖Disease Progression & Staging in Neurodegeneration80%
see_also📖Economic Burden — Neurodegeneration80%
see_also📖European Neurodegeneration Epidemiology80%
see_also📖Familial vs Sporadic Neurodegeneration Comparison80%
see_also📖Global Neurodegeneration Epidemiology80%
see_also📖India Neurodegeneration Epidemiology80%
see_also📖Japan Neurodegeneration Epidemiology80%
see_also📖Manganese-Related Neurodegeneration (Manganism)80%
see_also📖mitochondrial-dysfunction-neurodegeneration-comparison80%
see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr80%
see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 80%
see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)80%
see_also📖Potential Impact Measures — Neurodegeneration80%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)80%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)80%
see_also📖PLA2G6-Associated Neurodegeneration (PLAN)80%
see_also📖Sleep Disorders in Neurodegeneration80%
see_also📖US Neurodegeneration Epidemiology80%
see_also📖acetylcholine-signaling-neurodegeneration80%
see_also📖Advanced Glycation End Products in Neurodegeneration80%
see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 80%
see_also📖Amylin Signaling in Neurodegeneration80%
see_also📖Antibody Therapy in Neurodegeneration80%
see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration80%
see_also📖Autosis Pathway in Neurodegeneration80%
see_also📖Axon Guidance Pathways in Neurodegeneration80%
see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration80%
see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain80%
see_also📖CaMKII Signaling Pathway in Neurodegeneration80%
see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration80%
see_also📖Cholinergic System Dysfunction in Neurodegeneration80%
see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat80%
see_also📖Neural Circuits in Neurodegeneration80%
see_also📖Cognitive Reserve and Resilience in Neurodegeneration80%
see_also📖Computational Disease Models for Neurodegeneration80%
see_also📖Convergent Pathways in Neurodegeneration80%
see_also📖Copper Homeostasis in Neurodegeneration80%
see_also📖COVID-19 Neurodegeneration Mechanism80%
see_also📖Diffusion MRI (DTI) in Neurodegeneration80%
see_also📖Digital Phenotyping in Neurodegeneration80%
see_also📖Down Syndrome Neurodegeneration Pathway80%
see_also📖Dystrophic Neurites in Neurodegeneration80%
see_also📖Endocannabinoid System in Neurodegeneration80%
see_also📖Endothelin Signaling Pathway in Neurodegeneration80%
see_also📖epigenetics-neurodegeneration80%
see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration80%
see_also📖FA2H-Associated Neurodegeneration Pathway80%
see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration80%
see_also📖Galectin-3 Mechanism in Neurodegeneration80%
see_also📖Gangliosides in Neurodegeneration80%
see_also📖GDF15/GDF11 Signaling in Neurodegeneration80%
see_also📖GDNF Signaling Pathway in Neurodegeneration80%
see_also📖Ghrelin Signaling Pathway in Neurodegeneration80%
see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration80%
see_also📖Glycosylation in Neurodegeneration80%
see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration80%
see_also📖Hippocampal Neurogenesis in Neurodegeneration80%
see_also📖Histone Modification Pathways in Neurodegeneration80%
see_also📖HMGB1 Signaling in Neurodegeneration80%
see_also📖Homocysteine Neurotoxicity and Neurodegeneration80%
see_also📖IGF-1 Signaling Pathway in Neurodegeneration80%
see_also📖IL-1 Signaling Pathway in Neurodegeneration80%
see_also📖Integrated Stress Response in Neurodegeneration80%
see_also📖interleukin-6-signaling-neurodegeneration80%
see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration80%
see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 80%
see_also📖Kidney-Brain Neurodegeneration Axis80%
see_also📖Lipid Dysregulation in Neurodegeneration80%
see_also📖Lipid Metabolism Dysregulation in Neurodegeneration80%
see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration80%
see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration80%
see_also📖Metal Homeostasis Dysregulation in Neurodegeneration80%
see_also📖Metal Homeostasis in Neurodegeneration80%
see_also📖Microglial Priming Pathway in Neurodegeneration80%
see_also📖MicroRNA Dysfunction in Neurodegeneration80%
see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration80%
see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration80%
see_also📖Mitochondrial Fusion in Neurodegeneration80%
see_also📖Molecular Chaperones in Neurodegeneration80%
see_also📖mTOR Signaling in Neurodegeneration80%
see_also📖mTOR Signaling Pathway in Neurodegeneration80%
see_also📖Neural Circuit Disruption in Neurodegeneration80%
see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N80%
see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati80%
see_also📖Neuronal Hyperexcitability in Neurodegeneration80%
see_also📖Neuropil Threads in Neurodegeneration80%
see_also📖Neurotensin Signaling in Neurodegeneration80%
see_also📖NF-kB Signaling Pathway in Neurodegeneration80%
see_also📖Nitric Oxide Signaling in Neurodegeneration80%
see_also📖Noradrenergic Signaling Pathway in Neurodegeneration80%
see_also📖Neuropeptide Y Signaling in Neurodegeneration80%
see_also📖NRF2 Signaling Pathway in Neurodegeneration80%
see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration80%
see_also📖Orexin Signaling in Neurodegeneration80%
see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration80%
see_also📖P-Body (Processing Body) Pathway in Neurodegeneration80%
see_also📖Paranodal Dysfunction in Neurodegeneration80%
see_also📖Paraptosis in Neurodegeneration80%
see_also📖Parthanatos in Neurodegeneration80%
see_also📖Pericyte Loss in Neurodegeneration80%
see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration80%
see_also📖PKR Pathway in Neurodegeneration80%
see_also📖Prion Diseases in Neurodegeneration80%
see_also📖Prion-Like Spread in Neurodegeneration80%
see_also📖Prion Protein Metabolism in Neurodegeneration80%
see_also📖Progesterone Signaling Pathway in Neurodegeneration80%
see_also📖Prognostic Biomarkers in Neurodegeneration80%
see_also📖Protein Aggregation Comparison in Neurodegeneration80%
see_also📖Protein Aggregation Seeds in Neurodegeneration80%
see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration80%
see_also📖Cortical Involvement and Neurodegeneration in Progressive Su80%
see_also📖Purinergic Signaling in Neurodegeneration80%
see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener80%
see_also📖R-Loop Stress in Neurodegeneration80%
see_also📖RAN Translation in Neurodegeneration80%
see_also📖Retinal Degeneration Pathway in Neurodegeneration80%
see_also📖Ribosome Dysfunction in Neurodegeneration80%
see_also📖RNA Splicing in Neurodegeneration80%
see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a80%
see_also📖S100 Protein Signaling Pathway in Neurodegeneration80%
see_also📖Serotonergic Dysfunction in Neurodegeneration80%
see_also📖Sex Differences in Neurodegeneration80%
see_also📖Short Chain Fatty Acids in Neurodegeneration80%
see_also📖Sigma-1 Receptor Signaling in Neurodegeneration80%
see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration80%
see_also📖Sleep Dysfunction in Neurodegeneration80%
see_also📖SUMOylation in Neurodegeneration80%
see_also📖synaptic-vesicle-cycling-neurodegeneration80%
see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration80%
see_also📖T-Cell Dysfunction in Neurodegeneration80%
see_also📖Tertiary Lymphoid Organs in Neurodegeneration80%
see_also📖Therapeutic Targets in Neurodegeneration80%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration80%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration80%
see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration80%
see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration80%
see_also📖Vagus Nerve Pathway in Neurodegeneration80%
see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio80%
see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio80%
see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen80%
see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration80%
see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread80%
see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration80%
see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration80%
see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration80%
see_also📖Endosomal Sorting Defects in Neurodegeneration80%
see_also📖Neurovascular Unit Dysfunction in Neurodegeneration80%
see_also📖PPAR Signaling Pathway in Neurodegeneration80%
see_also📖RNA-Targeted Therapies in Neurodegeneration80%
see_also📖Senescent Cell Clearance in Neurodegeneration80%
mentions🔬What are the mechanisms underlying blood-brain barrier trans75%
mentions🔬What are the mechanisms underlying mitochondrial transfer be75%
mentions🔬What are the mechanisms underlying mitochondrial transfer be75%
mentions🔬What are the mechanisms underlying perivascular spaces and g75%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati75%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati75%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc75%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc75%
mentions🔬Senescent cell clearance as neurodegeneration therapy75%
see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE75%
see_also📖APOE4 (Apolipoprotein E4)75%
mentions🧪Temporal Decoupling via Circadian Clock Reset70%
mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 70%
mentions🧪Circadian-Synchronized Proteostasis Enhancement70%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer70%
mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu70%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones70%
mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations70%
mentions🧪LRP1-Dependent Tau Uptake Disruption70%
mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes70%
mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener70%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal70%
mentions🧪Low Complexity Domain Cross-Linking Inhibition70%
mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism70%
mentions🧪Circadian-Synchronized LRP1 Pathway Activation70%
mentions🧪SASP-Driven Aquaporin-4 Dysregulation70%
mentions🧪Axonal RNA Transport Reconstitution70%
mentions🧪Circadian-Gated Maresin Biosynthesis Amplification70%
mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming70%
mentions🧪Blood-Brain Barrier SPM Shuttle System70%
mentions🧪Stress Granule Phase Separation Modulators70%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction70%
mentions🧪Pharmacological Enhancement of APOE4 Glycosylation70%
mentions🧪Membrane Cholesterol Gradient Modulators70%
mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto70%
mentions🧪Flotillin-1 Stabilization Compounds70%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy70%
mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering70%
mentions🧪Lysosomal Positioning Dynamics Modulation70%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%
mentions🧪Aquaporin-4 Polarization Rescue70%
mentions🧪Competitive APOE4 Domain Stabilization Peptides70%
mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)70%
mentions🧪Phase-Separated Organelle Targeting70%
mentions🧪RNA Granule Nucleation Site Modulation70%
mentions🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation70%
mentions🧪APOE Isoform Expression Across Glial Subtypes70%
see_also📖LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for 65%
see_also📖nct0550878965%
see_also📖ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT0739265%
see_also📖remternetug-anti-amyloid-alzheimers65%
see_also📖UPenn Observational Research Repository (NCT04715399)65%
see_also📖APOE2 (Apolipoprotein E2)65%
see_also📖APOE3 (Apolipoprotein E3)65%
related🧪Temporal Decoupling via Circadian Clock Reset63%
related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 63%
related🧪Circadian-Synchronized Proteostasis Enhancement63%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer63%
related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu63%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones63%
related🧪Biorhythmic Interference via Controlled Sleep Oscillations63%
related🧪LRP1-Dependent Tau Uptake Disruption63%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes63%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener63%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal63%
related🧪Low Complexity Domain Cross-Linking Inhibition63%
related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism63%
related🧪Circadian-Synchronized LRP1 Pathway Activation63%
related🧪SASP-Driven Aquaporin-4 Dysregulation63%
related🧪Axonal RNA Transport Reconstitution63%
related🧪Circadian-Gated Maresin Biosynthesis Amplification63%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming63%
related🧪Blood-Brain Barrier SPM Shuttle System63%
related🧪Stress Granule Phase Separation Modulators63%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction63%
related🧪Pharmacological Enhancement of APOE4 Glycosylation63%
related🧪Membrane Cholesterol Gradient Modulators63%
related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto63%
related🧪Flotillin-1 Stabilization Compounds63%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy63%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering63%
related🧪Lysosomal Positioning Dynamics Modulation63%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides63%
related🧪Aquaporin-4 Polarization Rescue63%
related🧪Competitive APOE4 Domain Stabilization Peptides63%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)63%
related🧪Phase-Separated Organelle Targeting63%
related🧪RNA Granule Nucleation Site Modulation63%
related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation63%
related🧪APOE Isoform Expression Across Glial Subtypes63%
see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh60%
see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime60%
see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di60%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI60%
see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St60%
see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451660%
see_also📖Neuroimaging for Parkinsonian Syndromes (NCT03872102)60%
see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime60%
mentions🔬Investigate how lipid raft composition (cholesterol metaboli60%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%
mentions🔬Extracellular vesicle biomarkers for early AD detection60%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba60%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise60%
mentions🔬Investigate prion-like spreading of tau pathology through co60%
mentions🔬What are the mechanisms by which tau pathology spreads throu60%
see_also📖EIF2A Gene60%
see_also📖FAS Gene60%
see_also📖Packard Center for ALS Research60%
see_also📖erk-mapk-signaling-neurodegeneration60%
see_also📖diseases-amyotrophic-lateral-sclerosis60%
see_also📖c9orf72-als-ftd-phenotype-mechanism60%
see_also📖Genes60%
see_also📖CNBP — Cellular Nucleic Acid Binding Protein60%
see_also📖DMPK Gene (Dystrophia Myotonica Protein Kinase)60%
see_also📖GAIN Gene - GABA-A Receptor Associated Protein Like 260%
see_also📖Dementia Australia60%
see_also📖MARK2 Gene60%
see_also📖Alzheimer's Disease Mechanism Index55%
mentions🧪Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar50%
mentions🧪Circadian Clock-Autophagy Synchronization50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di50%
related🔬Extracellular vesicle biomarkers for early AD detection50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Senescent cell clearance as neurodegeneration therapy50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬What are the mechanisms by which tau pathology spreads throu50%
related🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
see_also📖Cannabidiol for Alzheimer's Disease Prevention (NCT058250%
see_also📖CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD50%
see_also📖EI-1071 Immunomodulator for Alzheimer's Disease (NCT06750%
see_also📖ExPlas — Exercise Plasma Transfusion for Alzheimer's Di50%
see_also📖Latrepirdine (DMB-I) Phase 3 Trial for Alzheimer's Dise50%
see_also📖Master Screening Study to Determine Individuals With Potenti50%
see_also📖X/T + X-EC + Lecanemab Phase 2 (NCT07212062) — Alzheimer50%
see_also📖Exciva Alzheimer's Disease Phase 2/3 Trial50%
see_also📖TRAP-AD: Transcranial Photobiomodulation for Alzheimer'50%
see_also📖VY7523 Phase 1/2 Alzheimer's Disease Trial50%
see_also📖APOE Lipid Metabolism Pathway in Alzheimer's Disease50%
see_also📖APOE4 and Alzheimer's Disease Risk50%
see_also📖Endolysosomal Pathway in Alzheimer's Disease50%
see_also📖Alzheimer's Disease Biomarkers45%
see_also📖Aquaporin-4 (AQP4) - Glymphatic System Biomarker45%
see_also📖ASL Perfusion Biomarkers for Alzheimer's Disease45%
see_also📖Digital Biomarkers for Alzheimer's Disease45%
see_also📖Dried Blood Spot Biomarker Test for Alzheimer's Disease45%
see_also📖DTI Biomarkers for Alzheimer's Disease45%
see_also📖EEG Biomarkers for Alzheimer's Disease45%
see_also📖Eye-Tracking Digital Markers in Alzheimer's Disease45%
see_also📖Gait Biomarkers for Alzheimer's Disease45%
see_also📖GFAP in Alzheimer's Disease45%
see_also📖Inflammatory Biomarkers in Alzheimer's Disease45%
see_also📖Neurogranin - Alzheimer's Disease Biomarker45%
see_also📖NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease45%
see_also📖Ocular Fluid Biomarkers for Alzheimer's Disease45%
see_also📖Olfactory Biomarkers for Alzheimer's Disease45%
see_also📖Plasma Phospho-Tau Ratio Diagnostic Panel for Alzheimer'45%
see_also📖Salivary Biomarkers for Alzheimer's Disease45%
see_also📖Sleep Biomarkers for Alzheimer's Disease45%
see_also📖Speech and Cognitive Biomarkers for Alzheimer's Disease45%
see_also📖Synaptic Biomarkers for Alzheimer's Disease45%
see_also📖Tear Film Biomarkers in Alzheimer's Disease45%
see_also📖VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers45%
see_also📖Diffuse Amyloid Deposits in Alzheimer's Disease45%
see_also📖ACP-204 for Alzheimer's Disease Psychosis (NCT06159673)45%
see_also📖al002-trem2-agonist-alzheimers45%
see_also📖ASN90 Phase 2 Trial - Early Alzheimer's Disease (NCT05645%
see_also📖BIIB080 (MAPTRx) Antisense Oligonucleotide for Alzheimer45%
see_also📖BMS-986368 Phase 2 - Agitation in Alzheimer's Disease45%
see_also📖BMS-986446 Phase 2 Trial for Early Alzheimer's Disease45%
see_also📖Centella asiatica Phase 1 Trial for Alzheimer's Disease45%
see_also📖DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulat45%
see_also📖Donanemab TRAILBLAZER-ALZ 2 Trial45%
see_also📖Escitalopram for Agitation in Alzheimer's Disease (NCT045%
see_also📖EX039 Phase 2 (NCT05413655) — Oral Therapeutic for Alzheimer45%
see_also📖Fasudil for Early Alzheimer's Disease (FEAD) - NCT0636245%
see_also📖[F-18]Flornaptitril PET - Phase 3 for Alzheimer's Disea45%
see_also📖Foralumab Phase 2 Trial for Alzheimer's Disease45%
see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0645%
see_also📖Guanfacine NorAD - Phase 3 Trial for Alzheimer's Diseas45%
see_also📖IGC-AD1 for Agitation in Alzheimer's Disease (NCT05543645%
see_also📖ITI-1284 for Alzheimer's Disease Psychosis (NCT0654083345%
see_also📖KarXT (Xanomeline/Trospium) - Phase 3 for Alzheimer's D45%
see_also📖LEAF Trial - THC+CBD for Alzheimer's Disease Agitation 45%
see_also📖NCT03875638 - Levetiracetam for Alzheimer's Disease45%
see_also📖LHP588: P. gingivalis Targeting for Alzheimer's Disease45%
see_also📖MAR Polypill for Alzheimer's Disease (NCT06597058)45%
see_also📖Masupirdine for Alzheimer's Disease Agitation45%
see_also📖Masupirdine for Agitation in Alzheimer's Disease (NCT0545%
see_also📖MK-1167 Phase 2 AD Trial (MK-1167-008)45%
see_also📖MK-2214 for Early Alzheimer's Disease45%
see_also📖Nabilone for Agitation in Alzheimer's Disease (NCT0451645%
see_also📖NAB-IT: Nabilone for Agitation in Alzheimer's Disease45%
see_also📖A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month45%
see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M45%
see_also📖TRAILBLAZER-ALZ 3 (NCT05026866) — Donanemab for Preclinical 45%
see_also📖GV1001 for Moderate to Severe Alzheimer's Disease (NCT045%
see_also📖Biogen Alzheimer's Disease Phase 2 Trial (NCT05399888)45%
see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 45%
see_also📖CBD (Cannabidiol) for Alzheimer's Disease Agitation - N45%
see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0645%
see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial45%
see_also📖The Alzheimer's Disease Tau Platform Clinical Trial (NC45%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI45%
see_also📖NRTIs for Alzheimer's Disease - Phase 1 (NCT07210528)45%
see_also📖DMB-I (Latrepirdine) Phase 3 (NCT07251023) — Alzheimer'45%
see_also📖NCT06582706: Nicotinic Acid for Alzheimer's Disease45%
see_also📖NCT07262645: Near-Infrared Light Therapy for Mild-Moderate A45%
see_also📖NRTIs for Alzheimer's Disease: Targeting Type-I Interfe45%
see_also📖ONO-2020 for Alzheimer's Disease (NCT06881836)45%
see_also📖NCT06803823 - ONO-2020 for Agitation in Alzheimer's Dis45%
see_also📖Ozanimod for Alzheimer's Disease (NCT06862960)45%
see_also📖Piromelatine 20 mg for Mild Dementia Due to Alzheimer's45%
see_also📖PLX5622 CSF1R Inhibitor Trial in Early Alzheimer's Dise45%
see_also📖Probiotics in Mild Alzheimer's Disease (NCT06181513)45%
see_also📖Recombinant Human Serum Albumin for Alzheimer's Disease45%
see_also📖Senicapoc Alzheimer's Disease Trial - NCT0480424145%
see_also📖SHR-1707 for Alzheimer's Disease (NCT06199037)45%
see_also📖Siponimod for Alzheimer's Disease (NCT06639282)45%
see_also📖SNIFF-Combo: Intranasal Insulin + Empagliflozin for Alzheime45%
see_also📖SToP-AD: Suvorexant for Alzheimer's Disease Prevention45%
see_also📖Trontinemab (RO7126209) Phase 3 Trial — TRONTIER 2 (NCT0717045%
see_also📖UB-311 Alzheimer's Vaccination Trial45%
see_also📖Cross-National Cancer-Dementia Correlation and Shared Diseas45%
see_also📖Cancer-Dementia Inverse Correlation: Epidemiological Evidenc45%
see_also📖SNCA — Alpha-Synuclein Gene Entity Page45%
see_also📖CD33 Siglec Receptor Dysfunction Alzheimer's Disease Ca45%
see_also📖Cholinergic System Degeneration in Alzheimer's Disease45%
see_also📖EEG Microstates in Alzheimer's Disease45%
see_also📖Geniposide for Alzheimer's disease - immune biomarker t45%
see_also📖Glymphatic System in Alzheimer's Disease45%
see_also📖Locus Coeruleus Degeneration in Alzheimer's Disease45%
see_also📖Metal Ion Homeostasis in Alzheimer's Disease45%
see_also📖Mitochondrial Dysfunction in Alzheimer's Disease Pathwa45%
see_also📖Neuroinflammation in Alzheimer's Disease45%
see_also📖Neuroinflammation Hypothesis in Alzheimer's Disease45%
see_also📖Neurovascular Dysfunction in Alzheimer's Disease: Integ45%
see_also📖NLRP3 Inflammasome Pathway in Alzheimer's Disease45%
see_also📖NLRP3 Inflammasome Inhibitors for Parkinson's Disease45%
see_also📖Sex-Specific Mechanisms in Alzheimer's Disease45%
see_also📖Sleep and Circadian Dysfunction in Alzheimer's Disease45%
see_also📖Sporadic Alzheimer's Disease Pathway45%
see_also📖Synaptic Loss in Alzheimer's Disease Pathway45%
see_also📖Tau Kinase-Phosphatase Balance in Alzheimer's Disease45%
see_also📖Tau Kinase Signaling Cascade in Alzheimer's Disease45%
see_also📖Ubiquitin-Proteasome System Dysfunction in Alzheimer's 45%
see_also📖Vascular Dementia Mechanisms — Overlap with Alzheimer's45%
mentions🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT40%
mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise40%
mentions🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P40%
mentions🧫Non-Motor Symptom Progression in Parkinson's Disease — 40%
mentions🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&40%
mentions🔬Analyze circuit-level changes in neurodegeneration using All40%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub